| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |